[ad] Promote your company here. [ad]
Neupulse, a healthcare startup based out of Nottingham, is making waves in the industry with their innovative approach towards treating tic disorders. Using non-invasive, non-drug treatments, Neupulse’s peripheral nerve stimulation therapy has been able to significantly reduce tics in individuals with tic disorders without affecting their cognitive abilities. Let’s dive into their story and vision.
The Startup Journey: Neupulse’s Origins
Neupulse is the brand of Neurotherapeutics Ltd, a British company that specializes in neuromodulation technologies for the treatment of neurological and neuropsychiatric disorders. Their journey began with a simple question – what could be done to help individuals with tic disorders gain control over their tics? After speaking with patients and their families, they were inspired to utilize peripheral nerve stimulation as a means of changing the brain networks responsible for the production of tics.
The Innovation: Peripheral Nerve Stimulation
After extensive research and collaboration with medical professionals, Neupulse developed a safe and effective method of peripheral nerve stimulation therapy that delivers rhythmic patterns of mild electrical stimulation to the median nerve at the wrist. This, in turn, increases the power and synchronicity of brain oscillations related to the suppression of movements, leading to a significant reduction in tics and the urge-to-tic in individuals with tic disorders.
The Results: Non-Invasive and Non-Drug Solutions
Neupulse’s peripheral nerve stimulation therapy has demonstrated outstanding results, showing a remarkable decrease in tics without any negative impact on the patients’ cognitive functions. Moreover, their non-invasive and non-drug treatment makes it more accessible and affordable for those in need, especially during the ongoing pandemic when reaching out for medical help has become even more challenging.
The Future Vision: Expanding to Other Neurological Disorders
Neupulse is currently focused on tic disorders, but their innovative therapy could be applied to other neurological disorders such as epilepsy and Parkinson’s disease. They aspire to develop a range of neuromodulation-based therapies that are safe, effective, and affordable, making it accessible to people worldwide.
Neupulse’s work is a testament to what can be achieved when we listen to the needs of the people we serve. Their use of innovative peripheral nerve stimulation therapy, combined with an acute awareness of the challenges faced by patients with tic disorders, has created a truly groundbreaking approach towards the treatment of neurological and neuropsychiatric disorders.
Want to supercharge your brand’s visibility within the UK tech industry? Reach startup founders, investors, and C-level executives with sponsored articles on UKT.news. Connect with us and discover how our advertising solutions can propel your brand to new heights. Explore our Sponsored Articles & Partnerships Program here.